Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Whirl-Carrillo

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|September 9, 2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingJ A Johnson, L Gong, M Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics|September 30, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir PrescribingR S Gammal, M H Court, C E Haidar, et al.
Clinical Pharmacology and Therapeutics|February 16, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 UpdateJ A Johnson, K E Caudle, L Gong, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology and Therapeutics|September 9, 2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingJ A Johnson, L Gong, M Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics|September 30, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir PrescribingR S Gammal, M H Court, C E Haidar, et al.
Clinical Pharmacology and Therapeutics|February 16, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 UpdateJ A Johnson, K E Caudle, L Gong, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 2